Head of Promomed Group Bely: Areplivir will go on sale in early December 
Actions Areplivir will go on sale in early December. Such a term was named by the head of the Promomed group of companies, Pyotr Bely, RIA Novosti reports.
“From the beginning of December it will begin to go on sale. And we will be able to provide the entire country, all regions of the country, “he said, noting that a shortage and queue for the drug is not expected.
The registration of Areplivir in Russia became known on Friday, November 12. A multicenter clinical trial of the drug led by Academician of the Russian Academy of Sciences Dmitry Pushkar confirmed the efficacy and safety of the drug when used in hospitals.